Expertise in
10
conditions

Kyung-nam N. Koh

Olympic Road 43 Road 88, 
Seoul, KR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
10
conditions
Olympic Road 43 Road 88, 
Seoul, KR 

Overview

Kyung-nam Koh practices practicing medicine in Seoul, Republic of Korea.

Koh is highly rated in 10 conditions, according to our data. Their clinical expertise encompasses Langerhans Cell Histiocytosis, Hepatoblastoma, Reticulohistiocytoma, Histiocytosis, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 95 peer reviewed articles and participating in 3 clinical trials.

Locations

Olympic Road 43 Road 88, Seoul, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
Enrollment Status: Recruiting
Publish Date: September 04, 2026
Intervention Type: Drug
Study Drug: Oral Repotrectinib (TPX-0005)
Study Phase: Phase 1/Phase 2
A Phase 1/2, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
A Phase 1/2, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
Enrollment Status: Completed
Publish Date: January 13, 2026
Intervention Type: Drug
Study Drug: Avapritinib
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

95 Total Publications

Feasibility of therapeutic drug monitoring of asparaginase across multiple formulations in pediatric acute lymphoblastic leukemia.
Feasibility of therapeutic drug monitoring of asparaginase across multiple formulations in pediatric acute lymphoblastic leukemia.
Journal: Blood research
Published: April 21, 2026

Frequently Asked Questions about Kyung-nam N. Koh

Is Kyung-nam N. Koh a top-rated expert for Langerhans Cell Histiocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Kyung-nam N. Koh is classified as an Advanced expert for Langerhans Cell Histiocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kyung-nam N. Koh participate in research or clinical trials?

Yes. Kyung-nam N. Koh has published 95 articles and abstracts on conditions like Langerhans Cell Histiocytosis. You can view a list of Kyung-nam N. Koh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Koh's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 41 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile